What investigations are recommended for a young patient with a spontaneous intracerebral hemorrhage who has no history of hypertension or type‑2 diabetes mellitus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Recommended Investigations for Young Hemorrhagic Stroke Without Hypertension or Diabetes

In a young patient with spontaneous intracerebral hemorrhage (ICH) without hypertension or diabetes, you must perform acute CTA with venography to exclude macrovascular causes and cerebral venous thrombosis, followed by MRI/MRA if initial imaging is negative, and consider catheter angiography (DSA) if noninvasive studies remain inconclusive. 1

Initial Vascular Imaging (Within 24 Hours)

Perform CTA plus CT venography acutely as the first-line investigation. The 2022 AHA/ASA guidelines give this a Class 1 (strong) recommendation for young patients without hypertension 1. The diagnostic yield for finding a macrovascular cause in this population is approximately 17% on initial CTA 1.

Age and Location-Based Algorithm:

  • Lobar ICH and age <70 years: CTA + venography recommended 1
  • Deep/posterior fossa ICH and age <45 years: CTA + venography recommended 1
  • Deep/posterior fossa ICH and age 45-70 years WITHOUT hypertension: CTA + venography recommended 1

The absence of hypertension dramatically increases the likelihood of finding an underlying vascular malformation—from 9% in hypertensive patients to 44% in normotensive patients 2.

Secondary Imaging if CTA is Negative or Inconclusive

Obtain MRI with MRA including specific sequences to identify both macrovascular and microvascular causes 1:

Essential MRI Sequences:

  • T2-weighted gradient echo or susceptibility-weighted imaging (SWI)*: Detects microbleeds, cortical superficial siderosis, cavernous malformations 1
  • Contrast-enhanced T1-weighted sequences: Excludes neoplasm or underlying mass lesions 1
  • MRA: Evaluates for vascular malformations with >90% sensitivity compared to DSA 1

The combined diagnostic yield of CTA plus MRI/MRA reaches 18-23% 1. MRI has the advantage of simultaneously detecting vascular malformations AND providing clues about non-macrovascular causes like cerebral amyloid angiopathy, cavernous malformations, or malignancy 1.

Catheter Angiography (DSA) Indications

Proceed to DSA if noninvasive imaging is negative or inconclusive (Class 2a recommendation) 1. In the DIAGRAM study, DSA identified additional macrovascular causes in 13% of patients with negative CTA/MRI 1.

Specific DSA Indications:

  • Negative or inconclusive CTA/MRA in young patients without hypertension
  • Any suggestion of vascular abnormality on noninvasive imaging
  • Isolated intraventricular hemorrhage (very high yield: 63-67% across all ages) 2
  • Primary IVH without parenchymal hemorrhage (Class 1 recommendation) 1

Important caveat: DSA carries a 0.6% risk of permanent neurological sequelae 1, but remains the gold standard for detecting arteriovenous malformations, aneurysms, and dural arteriovenous fistulae.

Additional Laboratory and Clinical Investigations

While the guidelines focus on vascular imaging, comprehensive evaluation should include:

  • Coagulation studies: PT/INR, aPTT, platelet count (thrombocytopenia associated with higher mortality) 1
  • Toxicology screen: Substance use is present in 27.7% of young ICH patients 3
  • Complete blood count: Anemia associated with hemorrhagic expansion 1
  • Renal and liver function: Renal failure associated with poor outcomes 1

Rare Causes to Consider in Young Patients:

  • Arteriovenous malformations/aneurysms: 14% of young ICH vs. 3.6% in older adults 3
  • Moyamoya disease: 1.4% in young patients 3
  • Sickle cell disease: 1.1% in young patients 3
  • Pregnancy-related ICH: Consider in women of childbearing age 3
  • Cerebral venous thrombosis: Hence the importance of venography 1

Follow-Up Imaging Strategy

If initial DSA is negative and no clear microvascular diagnosis is established, repeat DSA at 3-6 months may be reasonable (Class 2b recommendation) to identify previously obscured vascular lesions 1. Similarly, repeat contrast-enhanced MRI at 3-6 months is often performed to exclude occult neoplasm 1.

Critical Pitfalls to Avoid

  1. Don't assume hypertensive hemorrhage without imaging: Even in deep locations, 48% of young normotensive patients have macrovascular causes 1
  2. Don't skip venography: Cerebral venous thrombosis can mimic arterial ICH and requires different treatment
  3. Don't delay vascular imaging: Perform CTA within the first few hours—it also helps identify patients at risk for hematoma expansion via spot sign 1
  4. Don't stop at negative CTA: The combined yield of CTA + MRI/MRA + DSA is 23%, meaning single modality misses cases 1

The evidence strongly supports aggressive vascular imaging in young patients without traditional risk factors, as approximately 1 in 4 to 1 in 7 will have an underlying macrovascular cause that influences acute management, surgical planning, and long-term prognosis 1.

References

Related Questions

In a 71‑year‑old woman with hypertension, type 2 diabetes, prior intracerebral hemorrhage, anemia, and recent memory decline who presents with an infected lower‑extremity amputation stump, what is the recommended management?
In an 87-year-old patient with an isolated intraventricular hemorrhage and no severe hypertension or external injury, is routine computed tomography angiography (CTA) indicated?
In a patient with an isolated intraventricular hemorrhage of unknown cause, who is under 70 years old, without severe hypertension or clear external injury, when should computed tomography angiography (CTA) be performed?
What are the precautions, dosing recommendations, and monitoring requirements for using adalimumab in patients with endocrine disorders such as diabetes, thyroid disease, and adrenal insufficiency?
What is the expected yearly increase in aortic root diameter for an adult without Marfan syndrome or other connective‑tissue disorder, given a current measurement of 4.3 cm?
What is the most likely diagnosis—Hashimoto thyroiditis, painless (silent) thyroiditis, subacute granulomatous thyroiditis, or secondary hypothyroidism—in a 40‑year‑old woman with weight gain, cold intolerance, elevated TSH, low free T4, and a non‑enlarged, non‑tender thyroid?
What systolic blood pressure reduction can be expected after a single oral dose of 25 mg promethazine?
What are the etiologies and management strategies for intra‑abdominal adhesive disease?
What is the maximum recommended daily dose of empagliflozin and gliclazide?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.